Search

everythinglearnresearchcommunity

for

Search:↓

SK2 channels help control sensory signals in rat muscle spindles and hair follicles.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Gp₄G promotes hair growth and improves skin health.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

GLP-1RA therapy may increase the risk of hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

SOD1 and KL are promising targets for new hair loss treatments.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Geranium sibiricum extract helps hair grow and is more effective than minoxidil but can be toxic in high concentrations.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Removing SIX1 in fat cells reduces skin fibrosis.